Logo image of IMMR

IMMERSION CORPORATION (IMMR) Stock Fundamental Analysis

NASDAQ:IMMR - Nasdaq - US4525211078 - Common Stock - Currency: USD

7.87  +0.14 (+1.81%)

After market: 7.8104 -0.06 (-0.76%)

Fundamental Rating

5

IMMR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 32 industry peers in the Technology Hardware, Storage & Peripherals industry. IMMR has a medium profitability rating, but doesn't score so well on its financial health evaluation. IMMR scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IMMR had positive earnings in the past year.
IMMR had positive earnings in 4 of the past 5 years.
IMMR had a positive operating cash flow in 4 of the past 5 years.
IMMR Yearly Net Income VS EBIT VS OCF VS FCFIMMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

1.2 Ratios

IMMR's Return On Assets of 2.86% is fine compared to the rest of the industry. IMMR outperforms 65.63% of its industry peers.
The Return On Equity of IMMR (14.75%) is better than 84.38% of its industry peers.
The Return On Invested Capital of IMMR (1.89%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for IMMR is significantly below the industry average of 16.14%.
The last Return On Invested Capital (1.89%) for IMMR is well below the 3 year average (9.10%), which needs to be investigated, but indicates that IMMR had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.86%
ROE 14.75%
ROIC 1.89%
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
IMMR Yearly ROA, ROE, ROICIMMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

IMMR's Profit Margin of 100.17% is amongst the best of the industry. IMMR outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of IMMR has grown nicely.
IMMR's Operating Margin of 52.85% is amongst the best of the industry. IMMR outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of IMMR has grown nicely.
Industry RankSector Rank
OM 52.85%
PM (TTM) 100.17%
GM N/A
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
IMMR Yearly Profit, Operating, Gross MarginsIMMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

2

2. Health

2.1 Basic Checks

IMMR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
IMMR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for IMMR has been increased compared to 5 years ago.
IMMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IMMR Yearly Shares OutstandingIMMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
IMMR Yearly Total Debt VS Total AssetsIMMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

IMMR has an Altman-Z score of 0.50. This is a bad value and indicates that IMMR is not financially healthy and even has some risk of bankruptcy.
IMMR's Altman-Z score of 0.50 is on the low side compared to the rest of the industry. IMMR is outperformed by 71.88% of its industry peers.
A Debt/Equity ratio of 0.81 indicates that IMMR is somewhat dependend on debt financing.
IMMR's Debt to Equity ratio of 0.81 is in line compared to the rest of the industry. IMMR outperforms 40.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Altman-Z 0.5
ROIC/WACC0.21
WACC9.04%
IMMR Yearly LT Debt VS Equity VS FCFIMMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.55 indicates that IMMR should not have too much problems paying its short term obligations.
IMMR has a Current ratio of 1.55. This is comparable to the rest of the industry: IMMR outperforms 50.00% of its industry peers.
A Quick Ratio of 0.72 indicates that IMMR may have some problems paying its short term obligations.
With a Quick ratio value of 0.72, IMMR is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.72
IMMR Yearly Current Assets VS Current LiabilitesIMMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.12% over the past year.
Measured over the past years, IMMR shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.60% on average per year.
The Revenue for IMMR has decreased by -11.81% in the past year. This is quite bad
Measured over the past years, IMMR shows a very negative growth in Revenue. The Revenue has been decreasing by -21.11% on average per year.
EPS 1Y (TTM)14.12%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%N/A
Revenue 1Y (TTM)-11.81%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%-22.96%

3.2 Future

Based on estimates for the next years, IMMR will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.87% on average per year.
The Revenue is expected to grow by 189.84% on average over the next years. This is a very strong growth
EPS Next Y75.07%
EPS Next 2Y62.1%
EPS Next 3Y10.87%
EPS Next 5YN/A
Revenue Next Year1039.86%
Revenue Next 2Y388.92%
Revenue Next 3Y189.84%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMMR Yearly Revenue VS EstimatesIMMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
IMMR Yearly EPS VS EstimatesIMMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.30, which indicates a rather cheap valuation of IMMR.
Based on the Price/Earnings ratio, IMMR is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, IMMR is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 2.40, the valuation of IMMR can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IMMR indicates a rather cheap valuation: IMMR is cheaper than 93.75% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, IMMR is valued rather cheaply.
Industry RankSector Rank
PE 6.3
Fwd PE 2.4
IMMR Price Earnings VS Forward Price EarningsIMMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

IMMR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IMMR is cheaper than 68.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.7
IMMR Per share dataIMMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

IMMR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IMMR may justify a higher PE ratio.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y62.1%
EPS Next 3Y10.87%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.22%, IMMR has a reasonable but not impressive dividend return.
IMMR's Dividend Yield is rather good when compared to the industry average which is at 1.92. IMMR pays more dividend than 93.75% of the companies in the same industry.
IMMR's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.22%

5.2 History

IMMR has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
IMMR Yearly Dividends per shareIMMR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DPN/A
EPS Next 2Y62.1%
EPS Next 3Y10.87%
IMMR Yearly Income VS Free CF VS DividendIMMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

IMMERSION CORPORATION

NASDAQ:IMMR (7/8/2025, 8:00:01 PM)

After market: 7.8104 -0.06 (-0.76%)

7.87

+0.14 (+1.81%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)03-12 2025-03-12/bmo
Earnings (Next)08-18 2025-08-18
Inst Owners58.8%
Inst Owner Change0%
Ins Owners5.29%
Ins Owner Change-2.92%
Market Cap254.99M
Analysts82.5
Price Target12.5 (58.83%)
Short Float %8.86%
Short Ratio6.84
Dividend
Industry RankSector Rank
Dividend Yield 2.22%
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date04-14 2025-04-14 (0.045)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.3
Fwd PE 2.4
P/S 7.52
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 2.1
EV/EBITDA 11.7
EPS(TTM)1.25
EY15.88%
EPS(NY)3.28
Fwd EY41.73%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.05
BVpS7.11
TBVpS3.74
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.86%
ROE 14.75%
ROCE 2.39%
ROIC 1.89%
ROICexc 2.3%
ROICexgc 2.8%
OM 52.85%
PM (TTM) 100.17%
GM N/A
FCFM N/A
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
ROICexc(3y)48.9%
ROICexc(5y)N/A
ROICexgc(3y)48.9%
ROICexgc(5y)N/A
ROCE(3y)11.5%
ROCE(5y)N/A
ROICexcg growth 3Y84.52%
ROICexcg growth 5YN/A
ROICexc growth 3Y84.52%
ROICexc growth 5Y-44.16%
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF N/A
Debt/EBITDA 10.37
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.72
Altman-Z 0.5
F-ScoreN/A
WACC9.04%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)109.51%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.12%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%N/A
EPS Next Y75.07%
EPS Next 2Y62.1%
EPS Next 3Y10.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.81%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%-22.96%
Revenue Next Year1039.86%
Revenue Next 2Y388.92%
Revenue Next 3Y189.84%
Revenue Next 5YN/A
EBIT growth 1Y-26.59%
EBIT growth 3Y101.23%
EBIT growth 5Y-19.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.65%
FCF growth 3YN/A
FCF growth 5Y-21.67%
OCF growth 1Y-48.69%
OCF growth 3Y909.9%
OCF growth 5Y-21.68%